Authors:
Therasse, P
Arbuck, SG
Eisenhauer, EA
Wanders, J
Kaplan, RS
Rubinstein, L
Verweij, J
Van Glabbeke, M
van Oosterom, AT
Christian, MC
Gwyther, SG
Citation: P. Therasse et al., New guidelines to evaluate the response to treatment in solid Tumors, J NAT CANC, 92(3), 2000, pp. 205-216
Authors:
Legler, JM
Ries, LAG
Smith, MA
Warren, JL
Heineman, EF
Kaplan, RS
Linet, MS
Citation: Jm. Legler et al., Brain and other central nervous system cancers: Recent trends in incidenceand mortality - Response, J NAT CANC, 92(1), 2000, pp. 77-78
Citation: De. Walters et Rs. Kaplan, Models of the transmembrane domains of the yeast mitochondrial citrate transport protein, J MOL MODEL, 6(10-11), 2000, pp. 587-594
Citation: Rs. Kaplan, Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma - Comment, NEUROSURGER, 46(1), 2000, pp. 60-61
Authors:
Kaplan, RS
Mayor, JA
Brauer, D
Kotaria, R
Walters, DE
Dean, AM
Citation: Rs. Kaplan et al., The yeast mitochondrial citrate transport protein - Probing the secondary structure of transmembrane domain IV and identification of residues that likely comprise a portion of the citrate translocation pathway, J BIOL CHEM, 275(16), 2000, pp. 12009-12016
Authors:
Xu, Y
Kakhniashvili, DA
Gremse, DA
Wood, DO
Mayor, JA
Walters, DE
Kaplan, RS
Citation: Y. Xu et al., The yeast mitochondrial citrate transport protein - Probing the roles of cysteines, Arg(181), and Arg(189) in transporter function, J BIOL CHEM, 275(10), 2000, pp. 7117-7124
Authors:
Kaplan, RS
Mayor, JA
Kotaria, R
Walters, DE
Mchaourab, HS
Citation: Rs. Kaplan et al., The yeast mitochondrial citrate transport protein: Determination of secondary structure and solvent accessibility of transmembrane domain IV using site-directed spin labeling, BIOCHEM, 39(31), 2000, pp. 9157-9163
Authors:
Bostwick, DG
Grignon, DJ
Hammond, MEH
Amin, MB
Cohen, M
Crawford, D
Gospadarowicz, M
Kaplan, RS
Miller, DS
Montironi, R
Pajak, TF
Pollack, A
Srigley, JR
Yarbro, JW
Citation: Dg. Bostwick et al., Prognostic factors in prostate cancer - College of American Pathologists Consensus Statement 1999, ARCH PATH L, 124(7), 2000, pp. 995-1000
Authors:
Legler, JM
Ries, LAG
Smith, MA
Warren, JL
Heineman, EF
Kaplan, RS
Linet, MS
Citation: Jm. Legler et al., Re: Brain and other central nervous system cancers: Recent trends in incidence and mortality - Response, J NAT CANC, 91(23), 1999, pp. 2050-2051
Authors:
Legler, JM
Ries, LAG
Smith, MA
Warren, JL
Heineman, EF
Kaplan, RS
Linet, MS
Citation: Jm. Legler et al., Brain and other central nervous system cancers: Recent trends in incidenceand mortality, J NAT CANC, 91(16), 1999, pp. 1382-1390
Authors:
Hankey, BF
Feuer, EJ
Clegg, LX
Hayes, RB
Legler, JM
Prorok, PC
Ries, LA
Merrill, RM
Kaplan, RS
Citation: Bf. Hankey et al., Cancer surveillance series: Interpreting trends in prostate cancer - Part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates, J NAT CANC, 91(12), 1999, pp. 1017-1024
Authors:
Cox, JD
Gallagher, MJ
Hammond, EH
Kaplan, RS
Schellhammer, PF
Crook, JM
Leibel, SA
Forman, JD
Grimm, PD
Zietman, AL
Hudson, MA
Schild, SA
Beyer, DC
Hussey, DH
Thames, H
Shipley, WU
Citation: Jd. Cox et al., Consensus statements on radiation therapy of prostate cancer: Guidelines for prostate re-biopsy after radiation and for radiation therapy with risingprostate-specific antigen levels after radical prostatectomy, J CL ONCOL, 17(4), 1999, pp. 1155-1163
Authors:
Kotaria, R
Mayor, JA
Walters, DE
Kaplan, RS
Citation: R. Kotaria et al., Oligomeric state of wild-type and cysteine-less yeast mitochondrial citrate transport proteins, J BIOENER B, 31(6), 1999, pp. 543-549
Authors:
Kaplan, MJ
Ellis, CN
Bata-Csorgo, Z
Kaplan, RS
Endres, JL
Fox, DA
Citation: Mj. Kaplan et al., Systemic toxicity following administration of sirolimus (formerly rapamycin) for psoriasis - Association of capillary leak syndrome with apoptosis oflesional lymphocytes, ARCH DERMAT, 135(5), 1999, pp. 553-557